These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 6890371

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Animal experiments on the safety pharmacology of lofexidine.
    Graf E, Sieck A, Wenzl H, Winkelmann J.
    Arzneimittelforschung; 1982; 32(8a):931-40. PubMed ID: 6890367
    [Abstract] [Full Text] [Related]

  • 4. Acute, subacute and chronic toxicity/Carcinogenicity of lofexidine.
    Tsai TH, Beitman RE, Gibson JP, Larson EJ, Friehe H, Fontaine R.
    Arzneimittelforschung; 1982; 32(8a):955-62. PubMed ID: 6890369
    [Abstract] [Full Text] [Related]

  • 5. Teratologic and reproductive studies of lofexidine.
    Tsai TH, Beitman RE, Gibson JP, Larson EJ.
    Arzneimittelforschung; 1982; 32(8a):962-6. PubMed ID: 6890370
    [Abstract] [Full Text] [Related]

  • 6. Toxicology and Carcinogenesis Studies of Hydrochlorothiazide (CAS No. 58-93-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1989 Jul; 357():1-194. PubMed ID: 12695784
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
    [Abstract] [Full Text] [Related]

  • 10. Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1992 Mar; 407():1-289. PubMed ID: 12621523
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. NTP Toxicology and Carcinogenesis Studies of Promethazine Hydrochloride (CAS No. 58-33-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Dec; 425():1-272. PubMed ID: 12616286
    [Abstract] [Full Text] [Related]

  • 15. Lofexidine, a new, antihypertensive imidazoline derivative. Clinical profile of action with single-drug treatment and in combination with hydrochlorothiazide.
    Aigner A, Schmidt U.
    Arzneimittelforschung; 1982 Dec; 32(8a):976-83. PubMed ID: 6890373
    [No Abstract] [Full Text] [Related]

  • 16. Biotransformation of lofexidine in humans.
    Midgley I, Fowkes AG, Chasseaud LF, Hawkins DR, Girkin R, Kesselring K.
    Xenobiotica; 1983 Feb; 13(2):87-95. PubMed ID: 6880242
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB, National Toxicology Program.
    Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.